The search for a potent α-glucosidase inhibitor from the fungus Biscogniauxia capnodes SWUF15-40 yielded eighteen compounds. A comprehensive analysis from NMR and MS data revealed three new α-pyrones, biscogniapyrones A–C (1–3), two new isocoumarins (5 and 6), and thirteen known compounds. The configurations were assigned from calculated 13C NMR chemical shifts and ECD spectra, together with 1H NMR analysis of Mosher esters. Several compounds exhibited effective inhibitory activity against α-glucosidase with IC50 values in the range of 0.041–0.257 mM, which are lower than the positive control, acarbose (IC50 0.713 mM). The proposed non-competitive mode of inhibition was deduced from Lineweaver–Burk plots together with Km and Vmax values. In silico dockings of the strongest inhibitor, compound 3 were studied. Three out of the five determined allosteric sites of the enzyme model were favorable, with closed free binding energies of roughly − 4.00 kcal/mol. The binding interactions observed between 3 and amino acids in the pocket sites were hydrogen bonding and hydrophobic interactions. These findings, therefore, provide opportunities for drug development processes to be carried out.
{"title":"Potential α-glucosidase inhibitors from cultures of Biscogniauxia capnodes SWUF15-40 fungus","authors":"Audomsak Churat, Praewpan Katrun, Chittima Laohpongspaisan, Wiyada Mongkolthanaruk, Chamaiporn Champasri, Pairot Moontragoon, Nuttika Suwannasai, Ek Sangvichien, Pakarapon Poonsukkho, Sirirath McCloskey","doi":"10.1007/s11418-025-01876-9","DOIUrl":"10.1007/s11418-025-01876-9","url":null,"abstract":"<div><p>The search for a potent <i>α</i>-glucosidase inhibitor from the fungus <i>Biscogniauxia capnodes</i> SWUF15-40 yielded eighteen compounds. A comprehensive analysis from NMR and MS data revealed three new <i>α</i>-pyrones, biscogniapyrones A–C (<b>1</b>–<b>3</b>), two new isocoumarins (<b>5</b> and <b>6</b>), and thirteen known compounds. The configurations were assigned from calculated <sup>13</sup>C NMR chemical shifts and ECD spectra, together with <sup>1</sup>H NMR analysis of Mosher esters. Several compounds exhibited effective inhibitory activity against <i>α</i>-glucosidase with IC<sub>50</sub> values in the range of 0.041–0.257 mM, which are lower than the positive control, acarbose (IC<sub>50</sub> 0.713 mM). The proposed non-competitive mode of inhibition was deduced from Lineweaver–Burk plots together with <i>K</i><sub>m</sub> and <i>V</i><sub>max</sub> values. In silico dockings of the strongest inhibitor, compound <b>3</b> were studied. Three out of the five determined allosteric sites of the enzyme model were favorable, with closed free binding energies of roughly − 4.00 kcal/mol. The binding interactions observed between <b>3</b> and amino acids in the pocket sites were hydrogen bonding and hydrophobic interactions. These findings, therefore, provide opportunities for drug development processes to be carried out.</p><h3>Graphical abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"79 3","pages":"488 - 498"},"PeriodicalIF":2.5,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143497650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-20DOI: 10.1007/s11418-024-01871-6
Yuwei Xie, Nali Cai, Xiaohua Liu, Liangliang He, Yiming Ma, Changyu Yan, Juan Liang, Shu-Hua Ouyang, Ao Luo, Yingzhi He, Jun Lu, Dang Ao, Jia Liu, Zhonglv Ye, Bin Liu, Rong-Rong He, Wen Li
Silent information regulator 5 (SIRT5) is the fifth member of the sirtuin family, which is mainly expressed in mitochondrial matrix. SIRT5 plays a key role in metabolism and antioxidant responses, and is an important regulator for maintaining intracellular homeostasis. Given its involvement in multiple cellular processes, dysregulation of SIRT5 activity is associated with a variety of diseases. This review explores the structural characteristics of SIRT5 that influence its substrate specificity, highlights recent research advances, and summarizes its four key enzymatic activities along with their corresponding substrates in disease contexts. We also discuss the natural products that modulate SIRT5 activity and identify potential targets of SIRT5 through virtual docking, which may provide new therapeutic avenues. Although the mechanism of SIRT5 in diseases needs to be further elucidated and deglutathionylation activities are still at an early stage, targeting SIRT5 and its substrates holds significant promise for the development of novel therapeutics.